Sigyn Therapeutics, Inc. SEC filings SIGY

Sigyn Therapeutics, Inc. has 175 filings in SEC EDGAR's recent list, going back to May 27, 2015. Its latest annual report, Form 10-K, was filed on Apr 15, 2025 for the period ended Dec 31, 2024. The latest quarterly report (Form 10-Q) was filed on Nov 14, 2025, covering the quarter ended Sep 30, 2025. The most recent current report (Form 8-K) was filed on Feb 20, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.

Sigyn Therapeutics, Inc. SEC filings
Form Description Filed Period
15-12G Deregistration Jul 16, 2026 —
NT 10-K Filing Mar 31, 2026 Dec 31, 2025
8-K Current report
Material agreement, Unregistered share sale
Feb 20, 2026 Feb 20, 2026
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
10-Q Quarterly report Sep 5, 2025 Jun 30, 2025
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Other events
Aug 15, 2025 Aug 14, 2025
NT 10-Q Filing Aug 15, 2025 Jun 30, 2025
10-Q Quarterly report May 20, 2025 Mar 31, 2025
NT 10-Q Filing May 15, 2025 Mar 31, 2025
10-K Annual report Apr 15, 2025 Dec 31, 2024
NT 10-K Filing Mar 31, 2025 Dec 31, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 7, 2025 Feb 26, 2025
8-K Current report
Officer or director change
Jan 16, 2025 Jan 11, 2025
8-K Current report
Bylaw or fiscal year change
Jan 6, 2025 Dec 30, 2024
10-Q Quarterly report Nov 19, 2024 Sep 30, 2024
NT 10-Q Filing Nov 15, 2024 Sep 30, 2024
8-K Current report
Unregistered share sale
Oct 16, 2024 Oct 7, 2024
8-K/A Amended current report
Unregistered share sale
Oct 16, 2024 Oct 4, 2024
8-K Current report
Unregistered share sale
Oct 7, 2024 Oct 4, 2024
RW Filing Aug 30, 2024 —
10-Q Quarterly report Aug 19, 2024 Jun 30, 2024
NT 10-Q Filing Aug 14, 2024 Jun 30, 2024
8-K Current report
Other events
Jun 6, 2024 Jun 6, 2024
8-K Current report
Other events
May 15, 2024 May 15, 2024
10-Q Quarterly report May 14, 2024 Mar 31, 2024
8-K Current report
Material agreement
Apr 16, 2024 Apr 16, 2024
S-1/A Amended registration statement Apr 10, 2024 —
10-K Annual report Feb 20, 2024 Dec 31, 2023
8-K Current report
Other events
Jan 31, 2024 Jan 31, 2024
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Jan 30, 2024 Jan 30, 2024
8-K Current report
Material agreement, Other events
Jan 11, 2024 Jan 9, 2024
8-K Current report
Regulation FD disclosure
Jan 8, 2024 Jan 4, 2024
8-K Current report
Officer or director change
Dec 12, 2023 Dec 6, 2023
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
8-K Current report
Other events
Oct 26, 2023 Oct 20, 2023
8-K Current report
Regulation FD disclosure
Oct 4, 2023 Oct 4, 2023
S-1/A Amended registration statement Sep 22, 2023 —
8-K Current report
Material agreement
Sep 19, 2023 Sep 14, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
Jul 7, 2023 Jun 30, 2023
8-K Current report
Other events
Jun 8, 2023 Jun 8, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
S-1/A Amended registration statement May 10, 2023 —
8-K Current report
Regulation FD disclosure
Apr 13, 2023 Apr 11, 2023
10-K Annual report Mar 31, 2023 Dec 31, 2022
S-1/A Amended registration statement Feb 28, 2023 —
S-1/A Amended registration statement Dec 23, 2022 —
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
S-1/A Amended registration statement Nov 7, 2022 —
8-K Current report
Officer or director change
Oct 5, 2022 Oct 3, 2022
S-1/A Amended registration statement Aug 30, 2022 —
10-Q Quarterly report Aug 15, 2022 Jun 30, 2022
S-1 Registration statement Jun 23, 2022 —
10-Q Quarterly report May 13, 2022 Mar 31, 2022
10-K Annual report Mar 21, 2022 Dec 31, 2021
8-K Current report
Material agreement, Officer or director change
Mar 9, 2022 Mar 9, 2022
8-K Current report
Other events
Mar 1, 2022 Feb 23, 2022
10-Q Quarterly report Nov 12, 2021 Sep 30, 2021
8-K/A Amended current report
Material agreement
Oct 26, 2021 Oct 20, 2021
8-K Current report
Material agreement, Unregistered share sale
Oct 25, 2021 Oct 20, 2021
10-Q Quarterly report Aug 16, 2021 Jun 30, 2021
10-Q Quarterly report May 17, 2021 Mar 31, 2021
8-K Current report
Material agreement, Unregistered share sale
May 14, 2021 May 10, 2021
10-K Annual report Apr 6, 2021 Dec 31, 2020
NT 10-K Filing Mar 31, 2021 Dec 31, 2020
8-K/A Amended current report Dec 30, 2020 Sep 30, 2020
10-Q Quarterly report Nov 9, 2020 Sep 30, 2020
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change in control, Officer or director change, Bylaw or fiscal year change
Oct 23, 2020 Aug 25, 2020
DEF 14C Information statement Sep 21, 2020 Sep 18, 2020
PRE 14C Filing Sep 9, 2020 Sep 9, 2020
8-K Current report
Material agreement, Other events
Aug 31, 2020 Aug 25, 2020
8-K Current report
Other events
Aug 10, 2020 Aug 10, 2020
10-Q Quarterly report Aug 7, 2020 Jun 30, 2020
10-Q Quarterly report May 15, 2020 Mar 31, 2020
8-K Current report
Bylaw or fiscal year change
May 12, 2020 May 12, 2020
10-K Annual report Mar 30, 2020 Dec 31, 2019
8-K Current report
Material agreement
Mar 16, 2020 Mar 12, 2020
DEF 14C Information statement Mar 10, 2020 Feb 24, 2020
PRE 14C Filing Feb 25, 2020 Feb 24, 2020
8-K/A Amended current report
Auditor change, Other events
Jan 6, 2020 Dec 12, 2019
8-K Current report
Auditor change, Other events
Jan 3, 2020 Dec 12, 2019
8-K Current report
Bylaw or fiscal year change
Nov 14, 2019 Nov 13, 2019
10-Q Quarterly report Nov 12, 2019 Sep 30, 2019
8-K Current report
Material agreement, New debt, Unregistered share sale
Oct 3, 2019 Sep 29, 2019
DEF 14C Information statement Oct 2, 2019 Oct 2, 2019
PRE 14C Preliminary information statement Sep 17, 2019 Sep 17, 2019
10-Q Quarterly report Aug 5, 2019 Jun 30, 2019
10-Q Quarterly report Apr 19, 2019 Mar 31, 2019
10-K Annual report Apr 1, 2019 Dec 31, 2018
8-K Current report
Material agreement, Acquisition or sale of assets
Jan 7, 2019 Jan 4, 2019
10-Q Quarterly report Nov 14, 2018 Sep 30, 2018
8-K Current report
Auditor change
Oct 17, 2018 Oct 8, 2018
10-Q Quarterly report Aug 13, 2018 Jun 30, 2018
10-Q Quarterly report May 15, 2018 Mar 31, 2018
10-K Annual report Apr 2, 2018 Dec 31, 2017
8-K Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
Feb 23, 2018 Feb 20, 2018
8-K Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
Jan 8, 2018 Jan 3, 2018
8-K Current report
Material agreement, New debt, Unregistered share sale, Bylaw or fiscal year change
Nov 16, 2017 Nov 10, 2017
D/A Filing Nov 16, 2017 —
10-Q Quarterly report Nov 13, 2017 Sep 30, 2017
8-K Current report
Regulation FD disclosure
Sep 5, 2017 Sep 5, 2017
10-Q Quarterly report Aug 14, 2017 Jun 30, 2017
8-K/A Amended current report
Acquisition or sale of assets
Aug 7, 2017 Aug 7, 2017
8-K Current report
Material agreement, Unregistered share sale
Jul 3, 2017 Jun 30, 2017
424B3 Prospectus Jun 2, 2017 —
424B3 Prospectus Jun 2, 2017 —
10-Q Quarterly report Jun 2, 2017 Mar 31, 2017
10-K/A Amended annual report May 31, 2017 Dec 31, 2016
10-K Annual report May 31, 2017 Dec 31, 2016
8-K Current report
Material agreement, Other events
May 31, 2017 May 30, 2017
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
May 24, 2017 May 19, 2017
NT 10-K Notification of late filing Apr 3, 2017 Dec 31, 2016
DEF 14A Proxy statement Feb 23, 2017 Feb 22, 2017
PRE 14A Preliminary proxy statement Feb 8, 2017 Feb 8, 2017
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale
Dec 2, 2016 Dec 1, 2016
D/A Filing Nov 15, 2016 —
8-K Current report
Material agreement, New debt, Unregistered share sale, Officer or director change
Nov 14, 2016 Nov 10, 2016
424B3 Prospectus Nov 14, 2016 —
10-Q Quarterly report Nov 14, 2016 Sep 30, 2016
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale
Nov 4, 2016 Nov 3, 2016
424B3 Prospectus Aug 5, 2016 —
10-Q Quarterly report Aug 4, 2016 Jun 30, 2016
424B3 Prospectus May 10, 2016 —
424B3 Prospectus May 10, 2016 —
10-Q Quarterly report May 9, 2016 Mar 31, 2016
EFFECT Filing May 4, 2016 —
CORRESP Letter to the SEC May 4, 2016 —
CORRESP Letter to the SEC Apr 22, 2016 —
POS AM Post effective amendment Apr 22, 2016 —
10-K Annual report Mar 30, 2016 Dec 31, 2015
8-K Current report
Auditor change
Mar 14, 2016 Mar 9, 2016
UPLOAD Letter from the SEC Mar 4, 2016 —
POS AM Filing Feb 26, 2016 —
UPLOAD Letter from the SEC Feb 10, 2016 —
POS AM Form pos am Jan 29, 2016 —
8-A12G Filing Jan 22, 2016 —
8-K Current report
Material agreement, Other events
Jan 22, 2016 Jan 21, 2016
D Filing Jan 4, 2016 —
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Other events
Dec 24, 2015 Dec 22, 2015
10-Q/A Amended quarterly report Dec 21, 2015 Sep 30, 2015
10-Q Quarterly report Dec 3, 2015 Sep 30, 2015
EFFECT Filing Oct 30, 2015 —
CORRESP Letter to the SEC Oct 28, 2015 —
S-1/A Amended registration statement Oct 22, 2015 —
UPLOAD Letter from the SEC Oct 21, 2015 —
S-1/A Amended registration statement Oct 8, 2015 —
UPLOAD Letter from the SEC Oct 1, 2015 —
S-1/A Amended registration statement Sep 22, 2015 —
UPLOAD Letter from the SEC Sep 10, 2015 —
S-1/A Amended registration statement Aug 18, 2015 —
CORRESP Letter to the SEC Aug 17, 2015 —
UPLOAD Letter from the SEC Jun 24, 2015 —
S-1 Registration statement May 27, 2015 —

Showing 153 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
SIGY (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Beverly Hills, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1642159
Former names
Reign Resources Corp (until Oct 23, 2020); Reign Sapphire Corp (until May 12, 2020)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.